Table 3.
IGF-1:IGFBP-3 ratio | |||||
---|---|---|---|---|---|
Quartile 1 | Quartile 2 | Quartile 3 | Quartile 4 | P value | |
Predominant type 1, no type 3/other lobule type (n) | (27/90) | (20/98) | (18/100) | (9/110) | |
Age and batch-adjusteda | 1 (reference) | 0.68 (0.33 to 1.39) | 0.60 (0.29 to 1.26) | 0.26 (0.11 to 0.64) | 0.01 |
Multivariate model 1b | 1 (reference) | 0.80 (0.38 to 1.67) | 0.75 (0.34 to 1.66) | 0.34 (0.13 to 0.86) | 0.10 |
Multivariate model 2c | 1 (reference) | 0.83 (0.39 to 1.76) | 0.75 (0.33 to 1.71) | 0.32 (0.12 to 0.83) | 0.09 |
Data from the Nurses' Health Study II presented as odds ratio (95% confidence interval) unless stated otherwise. aAge at biopsy (continuous), insulin-like growth factor 1 (IGF-1):insulin-like growth factor binding protein-3 (IGFBP-3) batch. bAge at biopsy (continuous), IGF-1:IGFBP-3 batch, body mass index (continuous), menopausal status (premenopausal/dubious; postmenopausal, no postmenopausal hormone use; postmenopausal, postmenopausal hormone use), histological category of benign breast disease (proliferative without atypia, proliferative with atypia). cMultivariate model 1 plus parity (nulliparous, parous), alcohol (none, < 1.5, 1.5 to 4.5, 4.5+ g/day).